DocCheck AG is a Germany-based Company. The Company is engaged in the healthcare sector. The are three main business areas: agency business, access business and retail business. The agency business develops and implements communication concepts for the healthcare and B2B market. The access business helps to grow community for medical professionals. It also includes online advertising, online market research, online studies. The retail business provides medical supplies and medical technology.

Employees

414

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
24/07/26	€11.60	+0.87%	2,471
23/07/26	€11.50	-2.54%	493
22/07/26	€11.80	0.00%	1
21/07/26	€11.80	0.00%	16
20/07/26	€11.80	-0.84%	819

Delayed Quote Xetra

More quotes

Income Statement and Estimates

More financial data

Market Closed - Xetra Other stock markets 16:35:43 24/07/2026 BST			5-day change	1st Jan Change
11.60 ^EUR	+0.87%		-2.52%	-5.69%

04-16	DocCheck AG announces Annual dividend, payable on June 02, 2026	CI
04-08	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	58.86M 67.01M 54.74M 50.23M 94.37M 6.45B 95.83M 650M 254M 3.17B 252M 246M 10.97B	P/E 2024	8.03x	P/E 2025	11.7x
Enterprise Value	41.27M 46.98M 38.38M 35.22M 66.17M 4.52B 67.19M 456M 178M 2.22B 176M 173M 7.69B	EV / Sales 2024	0.41x	EV / Sales 2025	0.81x
Free-Float	28.08%	Yield 2024	8.98%	Yield 2025	8.13%

04-16	DocCheck AG announces Annual dividend, payable on June 02, 2026	CI
04-08	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2025	CI
29/09/25	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2025	CI
15/04/25	DocCheck AG announces Annual dividend, payable on June 02, 2025	CI
09/04/25	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2024	CI
23/09/24	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2024	CI
11/04/24	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI
30/09/23	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2023	CI
13/04/23	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2022	CI
29/07/22	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2022	CI
14/04/22	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2021	CI
28/10/21	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2021	CI
15/04/21	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2020	CI

04-16	DocCheck : Information pursuant to Section 125 para. 2 German Stock Corporation Act (AktG) in connection with Section 125 para. 5 AktG, Article 4 para. 1 and Table 3 of the Annex to Implementing Regulation (EU) 2018/1212 (DocCheck Informationen nach 125 AktG und Tabelle 3 Blocke A bis F Durchfuhrungsverordnung EU 2018 1212 engl)	PU
15/04/25	DocCheck : Information pursuant to Section 125 para. 2 German Stock Corporation Act (AktG) in connection with Section 125 para. 5 AktG, Article 4 para. 1 and Table 3 of the Annex to Implementing Regulation (EU) 2018/1212 (2025 DocCheck Informationen nach 125 AktG englisch und Tabelle 3 Bloecke A to F)	PU
04/05/23	DD: DocCheck AG: Dr. Frank Antwerpes, buy	EQ
05/03/20	DocCheck AG : Notification and public disclosure of transactions by persons	EQ

DocCheck AG Share Price

Stocks

AJ91

DE000A1A6WE6

Healthcare Facilities & Services

Valuation: DocCheck AG

Chart: DocCheck AG

Latest news : DocCheck AG

Press Releases: DocCheck AG

News in other languages: DocCheck AG

Quotes and Performance

Course Extremes

Managers and Directors: DocCheck AG

Latest insider transactions

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

Income Statement and Estimates

05-28	DocCheck : Abstimmungsergebnisse (AJ91 Abstimmungsergebnisse HV2026)
05-28	DocCheck : Nachtrag (AJ91 1 Nachtrag)
05-25	Kalender der Dividendenausschüttungen und Hauptversammlungen vom 25. bis 29. Mai 2026
05-20	Vorläufige Zahlen zum ersten Quartal 2026
05-07	DocCheck : Jahresabschluss für das Geschäftsjahr 2025 und Lagebericht (DocCheck AG Einzelabschluss 31.12.2025 2)

1 day	+0.43%
1 week	-2.52%
Current month	+0.87%
1 month	-0.85%
3 months	-7.20%
6 months	-12.12%
Current year	-5.69%

1 week	11.5	12
1 month	11.3	12.4
Current year	10.8	15.9
1 year	10.8	15.9
3 years	7	15.9
5 years	7	37.4
10 years	6.7	37.4

Manager	Title	Age	Since
Frank Nicolas Antwerpes CEO	Chief Executive Officer	65	-
Philip Stadtmann DFI	Director of Finance/CFO	-	31/07/2019
Jens Knoop CTO	Chief Tech/Sci/R&D Officer	-	31/07/2019

Director	Title	Age	Since
Joachim Pietzko CHM	Chairman	-	14/12/2014
Winfried Leimeister BRD	Director/Board Member	-	31/12/1998
Karin Immenroth BRD	Director/Board Member	-	30/03/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DOCCHECK AG	+0.87%	-2.52%	-7.20%	+8.41%	66.34M
CVS HEALTH CORPORATION	+0.80%	+1.16%	+74.20%	+43.56%	136B
HCA HEALTHCARE, INC.	+1.51%	-0.92%	+8.19%	+34.04%	83.52B
FRESENIUS SE & CO. KGAA	+2.22%	+4.71%	+4.56%	+53.85%	27.44B
QUEST DIAGNOSTICS INCORPORATED	-0.02%	+8.81%	+33.66%	+57.83%	25.23B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+1.32%	0.00%	-14.98%	-28.49%	20.05B
TENET HEALTHCARE CORPORATION	+17.17%	+17.07%	+47.31%	+203.76%	17.14B
REDE D'OR SÃO LUIZ S.A.	-0.86%	-6.71%	+2.39%	-7.05%	14.55B
DAVITA INC.	+0.50%	+0.61%	+55.59%	+129.07%	15.04B
FRESENIUS MEDICAL CARE AG	+0.65%	+2.90%	-5.83%	-11.44%	12.98B
Average	+2.38%	+0.20%	+19.79%	+48.35%	35.24B
Weighted average by Cap.	+1.70%	+0.23%	+37.12%	+46.35%

	2024	2025
Net sales	53.79M 61.24M 50.02M 45.9M 86.24M 5.9B 87.57M 594M 232M 2.9B 230M 225M 10.02B	55.32M 62.98M 51.44M 47.2M 88.69M 6.07B 90.06M 611M 239M 2.98B 236M 231M 10.31B
Net income	5.28M 6.02M 4.91M 4.51M 8.47M 579M 8.6M 58.35M 22.79M 285M 22.58M 22.1M 985M	5.33M 6.07M 4.96M 4.55M 8.55M 585M 8.68M 58.91M 23.01M 288M 22.8M 22.31M 994M
Net Debt	-20.11M -22.89M -18.7M -17.16M -32.24M -2.2B -32.74M -222M -86.75M -1.08B -85.94M -84.09M -3.75B	-17.59M -20.03M -16.36M -15.01M -28.2M -1.93B -28.64M -194M -75.89M -948M -75.18M -73.56M -3.28B